The interaction of age and type 2 diabetes on executive function and memory in persons aged 35 years or older

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Van Eersel, Marlise E A ^a   Joosten, Hanneke ^a   Gansevoort, Ron T ^a   Dullaart, Robin P F ^a   Slaets, Joris P J ^a   Izaks, Gerbrand J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN;

ADULT; AGE; AGED; ALLELE; APOE EPSILON4; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; EXPERIMENTAL COGNITIVE TEST; FEMALE; GENE; GENOTYPE; HUMAN; LEARNING AND MEMORY TEST; MAJOR CLINICAL STUDY; MALE; MEMORY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; RUFF FIGURAL FLUENCY TEST; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; VISUAL ASSOCIATION TEST;

ADULT; AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEINS E; CARDIOVASCULAR DISEASES; COGNITION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EXECUTIVE FUNCTION; FEMALE; HETEROZYGOTE; HUMANS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS;

EID: 84893400249     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082991     Document Type: Article

References (46)

1. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053. (Pubitemid 38579764)
2. Klein R (1995) Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18: 258-268.
3. Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA 287: 2570-2581. (Pubitemid 34517204)
4. Arvanitakis Z, Schneider JA, Wilson RS, Li Y, Arnold SE, et al. (2006) Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 67: 1960-1965.
5. van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ (2006) Brain imaging in patients with diabetes: A systematic review. Diabetes Care 29: 2539-2548.
6. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol 5: 64-74. (Pubitemid 41790697)
7. Vagelatos NT, Eslick GD (2013) Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev 35: 152-160.
8. Cukierman T, Gerstein HC, Williamson JD (2005) Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 48: 2460-2469. (Pubitemid 41738208)
9. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics, Division of Health Interview Statistics, data from the National Health Interview Survey (2010) Distribution of age at diagnosis of diabetes among adult incident cases aged 18-79 years. Available: http://www.cdc.gov/diabetes/ statistics/age/fig1.htm. Accessed 4 December 2012.
10. Pavlik VN, Hyman DJ, Doody R (2005) Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III). Neuroepidemiology 24: 42-50.
11. van Boxtel MP, Buntinx F, Houx PJ, Metsemakers JF, Knottnerus A, et al. (1998) The relation between morbidity and cognitive performance in a normal aging population. J Gerontol A Biol Sci Med Sci 53: M147-54.
12. Spauwen PJ, Kohler S, Verhey FR, Stehouwer CD, van Boxtel MP (2012) Effects of type 2 diabetes on 12-year cognitive change: Results from the Maastricht Aging Study. Diabetes Care, Publish ahead of print, published online 28 December 2012.
13. Knopman D, Boland LL, Mosley T, Howard G, Liao D, et al. (2001) Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 56: 42-48. (Pubitemid 32059650)
14. Nooyens AC, Baan CA, Spijkerman AM, Verschuren WM (2010) Type 2 diabetes and cognitive decline in middle-aged men and women: The Doetinchem Cohort Study. Diabetes Care 33: 1964-1969.
15. Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L (1999) The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 282: 40-46. (Pubitemid 29318931)
16. Caselli RJ, Dueck AC, Locke DE, Sabbagh MN, Ahern GL, et al. (2011) Cerebrovascular risk factors and preclinical memory decline in healthy APOE epsilon4 homozygotes. Neurology 76: 1078-1084.
17. Mahmoodi BK, Gansevoort RT, Veeger NJ, Matthews AG, Navis G, et al. (2009) Microalbuminuria and risk of venous thromboembolism. JAMA 301: 1790-1797.
18. Lambers Heerspink HJ, Brantsma AH, de Zeeuw D, Bakker SJ, de Jong PE, et al. (2008) Albuminuria assessed from first-morning-void urine samples versus 24- hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol 168: 897-905.
19. Ruff R (1996) Ruff Figural Fluency Test: Professional manual. Lutz, FL: Psychological Assessment Resources, Inc.
20. Ruff R, Light R, Evans R (1987) The Ruff Figural Fluency Test: A normative study with adults. Dev Neuropsychol 3: 37-51.
21. Izaks GJ, Joosten H, Koerts J, Gansevoort RT, Slaets JP (2011) Reference data for the Ruff Figural Fluency Test stratified by age and educational level. PLoS One 6: e17045.
22. Lindeboom J, Schmand B (2003) Visual Association Test. Manual. PITS B.V. Leiden, The Netherlands.
23. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 Suppl 1: S5-20.
24. Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT, PREVEND Study Group Prevention of REnal and Vascular ENT Stage Disease (2002) Pharmacy data in epidemiological studies: An easy to obtain and reliable tool. Pharmacoepidemiol Drug Saf 11: 379-384. (Pubitemid 35023468)
25. Izaks GJ, Gansevoort RT, van der Knaap AM, Navis G, Dullaart RP, et al. (2011) The association of APOE genotype with cognitive function in persons aged 35 years or older. PLoS One 6: e27415.
26. United Nations Educational, Scientific and Cultural Organization (2006) International standard classification of education ISCED 1997, May 2006 Reedition 2006. Available: http://www.uis.unesco.org/ev.php?ID=3813-201&D2= IDO-TOPIC. Accessed 4 December 2012.
27. De Jong PE, Hillege HL, Pinto-Sietsma SJ, de Zeeuw D (2003) Screening for microalbuminuria in the general population: a tool to detect subjects a risk for progressive renal failure in an early phase?. Nephrol Dial Transplant 18: 10-13. (Pubitemid 36104470)
28. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nat Genet 39: 17-23. (Pubitemid 46026496)
29. Baan CA, Nusselder WJ, Barendregt JJ, Ruwaard D, Bonneux L, et al. (1999) The burden of mortality of diabetes mellitus in the Netherlands. Epidemiology 10: 184-187. (Pubitemid 29093958)
30. Harris MI, Klein R, Welborn TA, Knuiman MW (1992) Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 15: 815-819.
31. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, et al. (2012) Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 125: e2-e220.
32. Moreira PI, Duarte AI, Santos MS, Rego AC, Oliveira CR (2009) An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease. J Alzheimers Dis 16: 741-761.
33. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, et al. (2007) Blood cholesterol and vascular mortality by age, sex, and blood pressure: a metaanalysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370: 1829-1839.
34. Sabayan B, Gussekloo J, de Ruijter W, Westerdorp RG, de Craen AJ (2013) Framingham stroke risk score and cognitive impairment for predicting first-time stroke in the oldest old. Stroke 44: 1866-1871.
35. Bild DE, Detrano R, Peterson D, Guerci A, Liu K, et al. (2005) Ethnic differences in coronary calcification: The Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 111: 1313-1320. (Pubitemid 40389097)
36. Sacco RL, Roberts JK, Boden-Albala B, Gu Q, Lin IF, et al. (1997) Raceethnicity and determinants of carotid atherosclerosis in a multiethnic population. the Northern Manhattan Stroke Study. Stroke 28: 929-935. (Pubitemid 27209135)
37. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ (1995) The association between midlife blood pressure levels and late-life cognitive function. the Honolulu-Asia Aging Study. JAMA 274: 1846-1851. (Pubitemid 26001260)
38. Ott A, Andersen K, Dewey ME, Letenneur L, Brayne C, et al. (2004) Effect of smoking on global cognitive function in nondemented elderly. Neurology 62: 920-924. (Pubitemid 38435779)
39. Manolio TA, Olson J, Longstreth WT (2003) Hypertension and cognitive function: Pathophysiologic effects of hypertension on the brain. Curr Hypertens Rep 5: 255-261. (Pubitemid 38914969)
40. Folsom AR, Rasmussen ML, Chambless LE, Howard G, Cooper LS, et al. (1999) Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. the Atherosclerosis Risk In Communities (ARIC) study investigators. Diabetes Care 22: 1077-1083. (Pubitemid 29293959)
41. Craft S, Watson GS (2004) Insulin and neurodegenerative disease: Shared and specific mechanisms. Lancet Neurol 3: 169-178. (Pubitemid 38229951)
42. Cummings JL, Cole G (2002) Alzheimer disease. JAMA 287: 2335-2338. (Pubitemid 34493187)
43. Gispen WH, Biessels GJ (2000) Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 23: 542-549.
44. Bu G (2009) Apolipoprotein E and its receptors in alzheimer's disease: Pathways, pathogenesis and therapy. Nat Rev Neurosci 10: 333-344.
45. Matthews FE, Chatfield M, Brayn C, Medical Research Council Cognitive Function and Ageing Study (2006) An investigation of whether factors associated with short-term attrition change or persist over ten years: data from the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). BMC Public Health 6: 185.
46. Joosten H, Izaks GJ, Slaets JP, de Jong PE, Visser ST, et al. (2011) Association of cognitive function with albuminuria and eGFR in the general population. Clin J Am Soc Nephrol 6: 1400-1409.